Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering

This poster presents an in-depth exploration of how light scattering techniques are employed to analyze glucagon-like peptide-1 analogs (GLP-1a)—a class of therapeutic peptides that play a critical role in the treatment of type 2 diabetes and obesity. By leveraging the precision of light scattering, researchers can gain valuable insights into the structural properties, aggregation behavior, and stability of GLP-1a compounds. These insights are essential for optimizing drug formulations and ensuring their efficacy and safety in clinical applications.

Discover how advanced analytical methods are shaping the future of metabolic disease treatment.